Optic Neuritis Treatment Market Players:
- Santen Pharmaceutical Co., Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mallinckrodt plc
- AbbVie Inc.
- Novartis AG
- Sanofi-aventis Groupe
- AdvoCare International
- Hikma Pharmaceuticals PLC
- Henry Schein, Inc.
- Fresenius Kabi USA
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of optic neuritis treatment is evaluated at USD 263.85 million.
The global optic neuritis treatment market size was worth around USD 253.8 million in 2025 and is set to register a CAGR of more than 4.4%, exceeding USD 390.39 million revenue by 2035.
North America in the optic neuritis treatment market is projected to account for a leading 35% revenue share by 2035, impelled by the higher adoption of steroids.
Key players in the market include United Imaging Healthcare Co., Ltd., Agfa-Gevaert Group, Canon Medical Systems Corporation (Canon Inc.), Hitachi, Ltd., GE Healthcare (General Electric Company), Carestream Health (ONEX Corporation), Koninklijke Philips N.V., Shenzen Mindray Bio-Medical Electronics Co., Ltd, Universal Hospital Services Inc., Althea Group.
